- Tel: 858.663.9055
- Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.
The stated application concentrations are suggested starting points. Titration of the Mitochondrial amidoxime reducing component 2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 270-300 from the human protein was used as the immunogen for the Mitochondrial amidoxime reducing component 2 antibody.
Aliquot the Mitochondrial amidoxime reducing component 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.